Three Former FDA Chiefs Urge FDA, CMS, Congress To Advance RWE Use

Three former FDA commissioners are calling on FDA, CMS and Congress to work with stakeholders to increase the use of real-world evidence (RWE) and real-world data (RWD) in order to improve the evidence base for new drugs and biologics; refine regulatory decisions by FDA; and promote value-based payment models to make health care more affordable. In a letter at the start of a 54-page report on RWE published by the Bipartisan Policy Center (BPC), former FDA chiefs Robert Califf, Andrew...